Cargando…
Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics
Since coronavirus disease 2019 (COVID-19) is a serious new worldwide public health crisis with significant morbidity and mortality, effective therapeutic treatments are urgently needed. Drug repurposing is an efficient and cost-effective strategy with minimum risk for identifying novel potential tre...
Autores principales: | Liu, Dan-Yang, Liu, Jia-Chen, Liang, Shuang, Meng, Xiang-He, Greenbaum, Jonathan, Xiao, Hong-Mei, Tan, Li-Jun, Deng, Hong-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069812/ https://www.ncbi.nlm.nih.gov/pubmed/33919660 http://dx.doi.org/10.3390/pharmaceutics13040545 |
Ejemplares similares
-
Repurposing Approved Drugs for Sarcopenia Based on Transcriptomics Data in Humans
por: Liang, Shuang, et al.
Publicado: (2023) -
A Mendelian randomization study for drug repurposing reveals bezafibrate and fenofibric acid as potential osteoporosis treatments
por: Li, Xiao-Hua, et al.
Publicado: (2023) -
Anti–SARS‐CoV‐2 Repurposing Drug Database: Clinical Pharmacology Considerations
por: Zhang, Xinyuan, et al.
Publicado: (2021) -
Exploration of the Anti-Inflammatory Drug Space Through Network Pharmacology: Applications for Drug Repurposing
por: de Anda-Jáuregui, Guillermo, et al.
Publicado: (2018) -
DrugRep: an automatic virtual screening server for drug repurposing
por: Gan, Jian-hong, et al.
Publicado: (2022)